Safety and Efficacy Study of Ladostigil in Mild to Moderate Probable Alzheimer's Disease

Clinical trial NCT01354691 · COMPLETED

Trial details

NCT number: NCT01354691
Sponsor: Avraham Pharmaceuticals Ltd
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Alzheimer's Disease Dementia Memory Loss Cognitive Impairment

Start date: 2011-02-01
Primary completion: 2012-09-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.